1. Guidelines for general practitioners (family doctors). Cough. 2015. (In Russ.) Руководства для врачей общей практики (семейных врачей). Кашель. 2015. https://www.volgmed. ru/uploads/files/2018-9/88994-kashel_2015.pdf.
2. Madison JM, Irwin RS. Cough. Comprehensive respiratory medicine. Ed. R. Albert, S. Spiro, J. Jett. 2nd ed. London: Harcourt Publishers Limitel, 2001. p. 15.1-15.6.
3. Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61, Suppl. 1:1-24.
4. Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur. Respir. J. 2007;29:1256-76.
5. Garg D, Srivastava AK, Dhamija RK. Beyond Fever, Cough and Dyspnea: The Neurology of COVID-19. J Assoc Physicians India. 2020;68(9):62-6.
6. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782- 93. doi:10.1001/jama.2020.12839.
7. Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. doi:10.1111/joim.13091.
8. Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in CoronavirusDisease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;296(2):E32- E40. doi:10.1148/radiol.2020200642.
9. Puzyrenko A, Felix JC, Ledeboer NA, et al. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis. Pathology. 2021:S0031-3025(21)00514-6. doi:10.1016/j.pathol.2021.09.005. Ahead of print.
10. Kaivola J, Nyman TA, Matikainen S. Inflammasomes and SARS-CoV-2 Infection. Viruses. 2021;13(12):2513. doi:10.3390/v13122513.
11. Mancia G, Rea F, Ludergnani M, et al. Renin-angiotensin-aldosterone system blockers andthe risk of COVID-19. N Engl J Med. 2020;382(25):2431-40. doi:10.1056/NEJMoa2006923.
12. Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, andneuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657-69. doi:10.1007/s10072-020-04575-3.
13. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID- 19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-61.
14. Alam SB, Willows S, Kulka M, Sandhu JK. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur J Neurol. 2020;27(11):2348-60. doi:10.1111/ene.14442.
15. Sungnak W, Huang N, Becavin C, et al. SARS‐CoV‐2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681-7.
16. Puzyrenko A, Felix JC, Sun Y, et al. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: case report and review of the literature. Pathol Res Pract. 2021;220:153380.
17. Vitiello A, Pelliccia C, Ferrara F. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy. SN Compr Clin Med. 2020:1-4. doi:10.1007/s42399-020-00487-7. Epub ahead of print.
18. Liu G, Philp AM, Corte T, et al. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacology & Therapeutics. 2021;225:107839. doi:10.1016/j. pharmthera.2021.107839.
19. Skibina AA, Bokov DO, Gravel IV, et al. HPLC-analysis of the phenolic complex of breast collection No. 4 and a dry extract based on it. Development and registration of medicines. 2019;8(2):98-102. (In Russ.) Скибина А. А., Боков Д. О., Гравель И. В. и др. ВЭЖХ-анализ фенольного комплекса грудного сбора № 4 и сухого экстракта на его основе. Разработка и регистрация лекарственных средств. 2019;8(2):98-102. doi:10.33380/2305-2066-2019-8-2-98-102.
20. Gravel IV, Levushkin DV, Mikheev IV, Skibina AA. The content of trace elements in breast collection No. 4. Traditional medicine. 2021;(3):19-26. (In Russ.) Гравель И. В., Лёвушкин Д. В., Михеев И. В., Скибина А. А. Содержание макроэлементов в грудном сборе № 4. Традиционная медицина. 2021;(3):19-26. doi:10.54296/18186173_ 2021_3_19.
21. Zaitsev AA, Okovity SV. Cough: differential diagnosis and rational pharmacotherapy. Therapeutic Archive. 2014;86(12):85-91. (In Russ.) Зайцев А. А., Оковитый С. В. Кашель: дифференциальный диагноз и рациональная фармакотерапия. Терапевтический архив. 2014;86(12):85-91.
22. Seifart C, Clostermann U, Seifart U, et al. Cell-specific modulation of surfactant proteins by ambroxol treatment. Toxicology and Applied Pharmacology. 2005;203(1):27-35.
23. Klyachkina IL, Sinopalnikov AI. Ambroxol in the program of treatment of chronic bronchopulmonary diseases. Practical pulmonology. 2018;2:83-92. (In Russ.)Клячкина И. Л., Синопальников А. И. Амброксол в программе лечения хронических бронхолегочных заболеваний. Практическая пульмонология. 2018;2:83-92.
24. Orlova NV. Cough in the review of modern recommendations. Medical advice. 2019;6:74-81. (In Russ.) Орлова Н. В. Кашель в обзоре современных рекомендаций. Медицинский совет. 2019;6:74-81. doi:10.21518/2079-701X-2019-6-74-81.